Format
Sort by
Items per page

Send to

Choose Destination

Best matches for guillain-barre syndrome AND influenza virus vaccine AND vaccination AND vaccines:

Search results

Items: 1 to 20 of 205

1.

Post Vaccination Guillain Barre Syndrome: A Case Report.

Wajih Ullah M, Qaseem A, Amray A.

Cureus. 2018 Apr 20;10(4):e2511. doi: 10.7759/cureus.2511.

PMID:
29930889
2.

Vaccine-preventable diseases, vaccines and Guillain-Barre' syndrome.

Principi N, Esposito S.

Vaccine. 2018 Jun 4. pii: S0264-410X(18)30798-9. doi: 10.1016/j.vaccine.2018.05.119. [Epub ahead of print] Review.

PMID:
29880241
3.

Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.

Xu K, Song Y, Dai L, Zhang Y, Lu X, Xie Y, Zhang H, Cheng T, Wang Q, Huang Q, Bi Y, Liu WJ, Liu W, Li X, Qin C, Shi Y, Yan J, Zhou D, Gao GF.

J Virol. 2018 Feb 26;92(6). pii: e01722-17. doi: 10.1128/JVI.01722-17. Print 2018 Mar 15.

PMID:
29298885
4.

MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination.

Eindhoven S, Levels J, Huisman M, de Winter KR, Dalm V, Alwani R.

Allergy Asthma Clin Immunol. 2017 Dec 13;13:49. doi: 10.1186/s13223-017-0222-9. eCollection 2017.

5.

Implementing near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD).

Leite A, Thomas SL, Andrews NJ.

Vaccine. 2017 Dec 14;35(49 Pt B):6885-6892. doi: 10.1016/j.vaccine.2017.09.022. Epub 2017 Oct 19.

6.

Making Vaccine Messaging Stick: Perceived Causal Instability as a Barrier to Effective Vaccine Messaging.

Dixon GN.

J Health Commun. 2017 Aug;22(8):631-637. doi: 10.1080/10810730.2017.1337832. Epub 2017 Jul 6.

PMID:
28682187
7.

Clinical Features of Post-Vaccination Guillain-Barré Syndrome (GBS) in Korea.

Park YS, Lee KJ, Kim SW, Kim KM, Suh BC.

J Korean Med Sci. 2017 Jul;32(7):1154-1159. doi: 10.3346/jkms.2017.32.7.1154.

8.

Near real-time surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14.

Sandhu SK, Hua W, MaCurdy TE, Franks RL, Avagyan A, Kelman J, Worrall CM, Ball R, Nguyen M.

Vaccine. 2017 May 19;35(22):2986-2992. doi: 10.1016/j.vaccine.2017.03.087. Epub 2017 Apr 24.

PMID:
28449973
9.

Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.

Baxter R, Eaton A, Hansen J, Aukes L, Caspard H, Ambrose CS.

Vaccine. 2017 Mar 1;35(9):1254-1258. doi: 10.1016/j.vaccine.2017.01.062. Epub 2017 Feb 2. Erratum in: Vaccine. 2017 May 25;35(23 ):3152.

11.

Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.

Alcalde-Cabero E, Almazán-Isla J, García López FJ, Ara-Callizo JR, Avellanal F, Casasnovas C, Cemillán C, Cuadrado JI, Duarte J, Fernández-Pérez MD, Fernández Ó, Merino JA, Montero RG, Montero D, Pardo J, Rodríguez-Rivera FJ, Ruiz-Tovar M, de Pedro-Cuesta J; Spanish GBS Epidemiology Study Group.

BMC Neurol. 2016 May 21;16:75. doi: 10.1186/s12883-016-0598-z.

12.

Guillain-Barré syndrome after trivalent influenza vaccination during pregnancy.

Tomimatsu T, Sugihara M, Nagai T, Sunada Y, Kimura T, Shimoya K.

Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:225-6. doi: 10.1016/j.ejogrb.2016.03.031. Epub 2016 Apr 1. No abstract available.

PMID:
27067284
13.

The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper.

Halsey NA, Talaat KR, Greenbaum A, Mensah E, Dudley MZ, Proveaux T, Salmon DA.

Vaccine. 2015 Dec 30;33 Suppl 5:F1-F67. doi: 10.1016/j.vaccine.2015.10.080. Review.

14.

[Adverse vaccination reaction does not automatically count as an occupational injury].

[No authors listed]

MMW Fortschr Med. 2015 Sep 10;157(15):11. doi: 10.1007/s15006-015-3447-x. German. No abstract available.

PMID:
26349701
15.

Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.

Saariaho AH, Vuorela A, Freitag TL, Pizza F, Plazzi G, Partinen M, Vaarala O, Meri S.

J Autoimmun. 2015 Sep;63:68-75. doi: 10.1016/j.jaut.2015.07.006. Epub 2015 Jul 27.

PMID:
26227560
16.

Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.

Ghaderi S, Gunnes N, Bakken IJ, Magnus P, Trogstad L, Håberg SE.

Eur J Epidemiol. 2016 Jan;31(1):67-72. doi: 10.1007/s10654-015-0047-0. Epub 2015 May 26.

PMID:
26008750
17.

Deaths following vaccination: What does the evidence show?

Miller ER, Moro PL, Cano M, Shimabukuro TT.

Vaccine. 2015 Jun 26;33(29):3288-92. doi: 10.1016/j.vaccine.2015.05.023. Epub 2015 May 23. Review.

18.

Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage.

Iqbal S, Li R, Gargiullo P, Vellozzi C.

Vaccine. 2015 Apr 21;33(17):2045-9. doi: 10.1016/j.vaccine.2015.02.064. Epub 2015 Mar 4.

PMID:
25749247
19.

Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.

Kim C, Rhie S, Suh M, Kang DR, Choi YJ, Bae GR, Choi YC, Jun BY, Lee JS.

Vaccine. 2015 Apr 8;33(15):1815-23. doi: 10.1016/j.vaccine.2015.02.035. Epub 2015 Feb 26.

PMID:
25728315
20.

Simulation study of the effect of influenza and influenza vaccination on risk of acquiring Guillain-Barré syndrome.

Hawken S, Kwong JC, Deeks SL, Crowcroft NS, McGeer AJ, Ducharme R, Campitelli MA, Coyle D, Wilson K.

Emerg Infect Dis. 2015 Feb;21(2):224-31. doi: 10.3201/eid2102.131879.

Supplemental Content

Loading ...
Support Center